High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis

M. H. Imam, E. Sinakos, A. A. Gossard, K. V. Kowdley, V. A.C. Luketic, M. Edwyn Harrison, T. McCashland, A. S. Befeler, D. Harnois, R. Jorgensen, J. Petz, J. Keach, A. C. Decook, F. Enders, K. D. Lindor

Research output: Contribution to journal › Article › peer-review

77 Scopus citations

Fingerprint

Dive into the research topics of 'High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry